Potential of osteopontin in the management of epithelial ovarian cancer
, , , und
31. Jan. 2019
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 31. Jan. 2019
Seitenbereich: 105 - 115
Eingereicht: 07. Sept. 2018
Akzeptiert: 27. Dez. 2018
DOI: https://doi.org/10.2478/raon-2019-0003
Schlüsselwörter
© 2019 Katarina Cerne, Benjamin Hadzialjevic, Erik Skof, Ivan Verdenik, Borut Kobal published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Cerne, Katarina
Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University LjubljanaLjubljana, Slovenia
Hadzialjevic, Benjamin
Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University LjubljanaLjubljana, Slovenia
Skof, Erik
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Verdenik, Ivan
Department of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre LjubljanaLjubljana, Slovenia
Department of Gynaecology and Obstetrics, Faculty of Medicine, University LjubljanaLjubljana, Slovenia
Kobal, Borut
Department of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre LjubljanaLjubljana, Slovenia
Department of Gynaecology and Obstetrics, Faculty of Medicine, University LjubljanaLjubljana, Slovenia